Patents by Inventor Mineo Takei

Mineo Takei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6395739
    Abstract: The present invention is directed to an N-phenyl-N′-phenylpropylpiperazine derivative represented by formula (1): (wherein R1 represents a lower alkyl group; R2 represents a lower alkoxy group; and R3 represents a cyano group, a carboxyl group, or an indolecarbonyl group); a medicament; and to a process for producing the derivative. The compound of the present invention is endowed with potent &agr;1-adrenoceptor blocking activity, and thus is useful for the prevention or treatment of hypertension, congestive heart failure, myocardinal ischemia, arrhythmia, angina pectoris, and urinary obstruction and pollakiuria caused by benign prostatic hyperplasia.
    Type: Grant
    Filed: December 29, 2000
    Date of Patent: May 28, 2002
    Assignee: Zeria Pharmaceutical Co., Ltd.
    Inventors: Hiroki Sato, Eiichi Nagano, Jun Chikazawa, Mineo Takei, Raita Higashino
  • Patent number: 6242449
    Abstract: The present invention is directed to 3-benzoylindole derivatives represented by the following formula (I): (wherein R1 represents a lower alkyl group, n is an integer from 1 to 5; each of R2 and R3 represents a hydrogen atom, a lower alkyl group, or an optionally substituted phenyl group; and R4 represents a hydrogen atom, a lower alkyl group, or a benzyl group) and to a pharmaceutical containing the same. This compound is endowed with strong &agr;1-adrenergic receptor blocking action and strong testosterone 5&agr;-reductase inhibitory action, as well as high level of safety, and thus is useful as an excellent preventive or therapeutic drug for prostatic hypertrophy or accompanying urination disorder, alopecia, and acne.
    Type: Grant
    Filed: January 6, 2000
    Date of Patent: June 5, 2001
    Assignee: Zeria Pharmaceutical Co., Ltd.
    Inventors: Hiroki Sato, Mineo Takei, Jun Chikazawa, Yoichi Fukuda, Eiichi Nagano
  • Patent number: 5760040
    Abstract: The present invention relates to an indole derivative represented by formula (1) or a salt thereof, and a pharmaceutical containing the derivative or the salt: ##STR1## wherein R.sup.1 represents lower alkyl; R.sup.2 represents hydrogen or phenyl which may be substituted by at least one lower alkyl, lower alkoxy or a halogen atom; R.sup.3 represents hydrogen, lower alkyl, lower alkoxy, or phenylalkyloxy which may be substituted by halogen or lower alkyl; R.sup.4 represents hydrogen, lower alkyl or lower alkoxy; R.sup.5 represents hydrogen or lower alkyl; and n represents an integer of 1 to 5. This compound has the effects of both blocking .alpha..sub.1 -adrenergic receptors and inhibiting testosterone 5.alpha.-reductases, and is useful as a remedy and/or a preventive for diseases caused by dihydrotestosterone overproduction, such as prostatic hypertrophy, and diseases accompanying the same, such as urination disorder, male pattern alopecia, acne, and so forth.
    Type: Grant
    Filed: May 5, 1997
    Date of Patent: June 2, 1998
    Assignee: Zeria Pharmaceutical Co., Ltd.
    Inventors: Kiyoshi Yoshida, Tadashi Kurimoto, Mineo Takei, Hiroki Sato